TY - JOUR
T1 - A first survey of HPV-based screening in routine cervical cancer screening in Italy
AU - HPV screening survey working group
AU - Ronco, Guglielmo
AU - Giorgi-Rossi, Paolo
AU - Giubilato, Pamela
AU - Mistro, Annarosa Del
AU - Zappa, Marco
AU - Carozzi, Francesca
AU - Segnan, N.
AU - Gillio Tos, A.
AU - Bonelli, L.
AU - Franco, A.
AU - Venturino, E.
AU - Pasquale, L.
AU - Luciano, G.
AU - Polla, E.
AU - Dalla Palma, P.
AU - Zorzi, M.
AU - Fedato, C.
AU - Zago, F.
AU - Pupo, A.
AU - Simoncello, I.
AU - Ferro, A.
AU - Gallo, L.
AU - Del Sole, A.
AU - Paterlini, L.
AU - Campari, C.
AU - Iossa, A.
AU - Confortini, M.
AU - Barca, A.
AU - Tufi, M. C.
AU - Bellardini, P.
AU - Fortunato, C.
AU - Minna, M.
AU - Macerola, A.
AU - Caraceni, D.
PY - 2015/5/1
Y1 - 2015/5/1
N2 - Pilot HPV-based cervical screening programmes have recently started in Italy, partly on the strength of a large randomized trial. The Ministry of Health recommended that regions shift toward HPV-based screening in early 2013 and provided guidelines for its application (stand-alone HPV testing by validated methods, cytological triage of HPV positives, beginning at age 30-35, 5-year intervals). A first survey on the 2012 activity was conducted in 2013. In 2012, 19 Italian organized cervical screening programmes from 10 regional programmes invited 311,856 women (8.0% of all women invited for cervical screening in 2012 in Italy) for HPV-based screening; 41.5% complied, with a decreasing North-South trend. Among screened women, 7.9% (range 4.3%-13.9%) were HPV positive, decreasing to 6.6% (range 4.0%-12.4%) when considering women aged 35-64 years. Among HPV positive women, 34.8% (with high variability between programmes: range 11.1%-59.3%) were judged to have ASC-US or more severe cytology (5.3% ASC-US, 26.6% L-SIL, 5.2% H-SIL). Out of all screened women, those referred to colposcopy based on HPV and cytology results were 2.9% (range 0.6%-4.8%), whereas they were 2.0% when considering only women aged 35-64 years.
AB - Pilot HPV-based cervical screening programmes have recently started in Italy, partly on the strength of a large randomized trial. The Ministry of Health recommended that regions shift toward HPV-based screening in early 2013 and provided guidelines for its application (stand-alone HPV testing by validated methods, cytological triage of HPV positives, beginning at age 30-35, 5-year intervals). A first survey on the 2012 activity was conducted in 2013. In 2012, 19 Italian organized cervical screening programmes from 10 regional programmes invited 311,856 women (8.0% of all women invited for cervical screening in 2012 in Italy) for HPV-based screening; 41.5% complied, with a decreasing North-South trend. Among screened women, 7.9% (range 4.3%-13.9%) were HPV positive, decreasing to 6.6% (range 4.0%-12.4%) when considering women aged 35-64 years. Among HPV positive women, 34.8% (with high variability between programmes: range 11.1%-59.3%) were judged to have ASC-US or more severe cytology (5.3% ASC-US, 26.6% L-SIL, 5.2% H-SIL). Out of all screened women, those referred to colposcopy based on HPV and cytology results were 2.9% (range 0.6%-4.8%), whereas they were 2.0% when considering only women aged 35-64 years.
KW - Cervical cancer
KW - HPV test
KW - Italy
KW - Mass screening
UR - http://www.scopus.com/inward/record.url?scp=85016132861&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85016132861&partnerID=8YFLogxK
M3 - Article
C2 - 26405779
AN - SCOPUS:85016132861
VL - 39
SP - 77
EP - 83
JO - Epidemiologia e prevenzione
JF - Epidemiologia e prevenzione
SN - 1120-9763
IS - 3
ER -